Alpha Tau Medical Ltd
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -70.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | -7.5% | +0.0% | +74.5% | +0.0% | -18.2% | +36.9% | +1.2% | -74.4% | +574.6% | +4.1% | -11.4% | +11.5% | +17.2% | -5.6% | +12.1% | +12.2% | -13.9% | +6.5% | -10.1% | +22.0% | -4.8% | -2.2% | +18.5% | +15.3% | +14.6% | -9.7% | – | |
| – | +0.0% | +0.0% | +0.0% | -11.6% | +0.0% | +32.6% | +0.0% | -5.8% | +4.0% | +26.9% | +17.6% | +467.7% | -26.8% | -6.5% | -3.3% | -12.2% | -12.6% | +0.4% | +17.7% | -27.9% | +10.0% | +0.0% | +29.3% | -18.3% | +29.7% | -11.2% | +33.2% | -18.5% | +70.0% | – | |
| – | – | – | – | – | +0.0% | +42.1% | +0.0% | +0.8% | +27.2% | +4.5% | -90.0% | +2,304.8% | -8.8% | -8.2% | -4.8% | +23.4% | -11.4% | +16.6% | -0.6% | -5.0% | +7.5% | -8.4% | +23.9% | -9.4% | +3.7% | +11.2% | +17.4% | +5.6% | +3.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +146.4% | +0.0% | +0.0% | +0.0% | +6,796.2% | -61.1% | -66.5% | +1,083.0% | +22.8% | -64.5% | -21.2% | +67.9% | -94.0% | – | – | – | – | – | – | – | – | – | – | – | – | +230.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +98.6% | +0.0% | -91.0% | +0.0% | +69.2% | +36.4% | -133.3% | – | -71.4% | +200.0% | +50.0% | -66.7% | +600.0% | +23.8% | -250.0% | – | -87.5% | +200.0% | – | – | +4,850.0% | -34.3% | -112.3% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.